COMP <GO>
DCTH vs RCEL // GROSS PROFIT MARGIN
Delcath Systems Inc. (NASDAQ) VS. Avita Medical Inc. (NASDAQ) • 15-METRIC TALLY: DCTH 7
— RCEL 2
▲ GROSS PROFIT MARGIN LEADER: DCTH
LAST: $14.64 (-1.48%) • MKT CAP: $508.0M
gross-margins
86.20%
LAST: $16.71 (+1.27%) • MKT CAP: $516.8M
gross-margins
82.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DCTH VS. RCEL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DCTH | RCEL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | 86.20% | 82.10% | +4.10 | DCTH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 0.80% | -35.00% | +35.80 | DCTH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.13% | -6.23% | +10.36 | DCTH | /fcf-yield <GO> |
| Operating Margin | 0.80% | -59.40% | +60.20 | DCTH | /operating-margins <GO> |
| Net Profit Margin | 3.20% | -60.00% | +63.20 | DCTH | /net-margins <GO> |
| Revenue Growth (YoY) | 129.10% | 11.50% | +117.60 | DCTH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 20.33 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | DCTH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.3 | 66.2 | -28.87 | RCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $508.0M | $516.8M | -$8.8M | RCEL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DCTH REV | RCEL REV | DCTH GROSS % | RCEL GROSS % | DCTH FCF | RCEL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $85.2M | $71.6M | 86.2% | 82.1% | $21.0M | -$32.2M |
| FY 2024 | $37.2M | $64.3M | 83.4% | 85.8% | -$19.2M | -$58.1M |
| FY 2023 | $2.1M | $50.1M | — | — | -$31.3M | -$38.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DCTH // BETA —
RCEL // BETA —